Literature DB >> 21621869

Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: a large population-based study.

Marta Baviera1, Lara Monesi, Irene Marzona, Fausto Avanzini, Gabriella Monesi, Alessandro Nobili, Mauro Tettamanti, Emma Riva, Laura Cortesi, Angela Bortolotti, Ida Fortino, Luca Merlino, Giancarlo Fontana, Maria Carla Roncaglioni.   

Abstract

OBJECTIVE: To analyze the prescribing patterns of antidiabetic and cardiovascular medications among diabetics in the most highly populated Italian Region, from 2000 to 2008.
METHODS: Data were obtained from the Lombardy Region administrative health databases. The standardized prevalence of antidiabetic and cardiovascular drugs use was calculated within each study year. The prescription trends of initial treatment with antidiabetic drugs were also analyzed.
RESULTS: From 2000 to 2008 there was an increase in the proportion of patients treated with biguanides (from 53.4% to 66.5%; p<0.0001) while those receiving sulfonylurea decreased (from 78.6% to 56.4%; p<0.0001). A sharp increase of metformin (as monotherapy) as initial treatment was also observed (from 15.2% to 48.8%; p<0.0001). The percentage of patients receiving renin-angiotensin system inhibitors, lipid-lowering drugs and antiplatelets increased between 2000 and 2008, from respectively 45.1% to 63.3%, 13.6% to 43.2% and 21.6% to 40.9 (p<0.0001). Multivariate analyses indicated that changes in prescriptions were statistically significant for both antidiabetic and cardiovascular drugs.
CONCLUSION: This study documents progressive changes in the prescription of antidiabetic and cardiovascular drugs in accordance with guidelines. However, the use of metformin as first line therapy was still suboptimal and cardiovascular preventive strategies were only partially implemented in community practice.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621869     DOI: 10.1016/j.diabres.2011.05.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  15 in total

1.  Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization.

Authors:  Hsiang-Yin Chen; Pei-Yin Chiu; Ching-Jun Chang; Lih-Ling Tsai; Ya-Lan Huang; Jason C Hsu
Journal:  Clin Drug Investig       Date:  2018-12       Impact factor: 2.859

2.  Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.

Authors:  Ronan T Grimes; Kathleen Bennett; Lesley Tilson; Cara Usher; Susan M Smith; Martin C Henman
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

3.  Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003-2012.

Authors:  N L Zaharan; D Williams; K Bennett
Journal:  Ir J Med Sci       Date:  2013-09-07       Impact factor: 1.568

4.  Changes in prescribing patterns and clinical outcomes in elderly diabetic patients in 2000 and 2010: analysis of a large Italian population-based study.

Authors:  Marta Baviera; Laura Cortesi; Mauro Tettamanti; Fausto Avanzini; Giuseppe Marelli; Irene Marzona; Alessandro Nobili; Emma Riva; Ida Fortino; Angela Bortolotti; Luca Merlino; Maria Carla Roncaglioni
Journal:  Eur J Clin Pharmacol       Date:  2014-05-14       Impact factor: 2.953

5.  National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus.

Authors:  Jisu Kim; Susin Park; Hyunsoo Kim; Nam Kyung Je
Journal:  Eur J Clin Pharmacol       Date:  2019-09-02       Impact factor: 2.953

Review 6.  Advances in pharmacologic therapies for type 2 diabetes.

Authors:  Linde M Morsink; Mark M Smits; Michaela Diamant
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

7.  Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies.

Authors:  Jason C Hsu; Dennis Ross-Degnan; Anita K Wagner; Ching-Lan Cheng; Yea-Huei Kao Yang; Fang Zhang; Christine Y Lu
Journal:  J Pharm Policy Pract       Date:  2015-04-25

8.  Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32).

Authors:  Mariko Oishi; Katsuya Yamazaki; Fuminobu Okuguchi; Hidekatsu Sugimoto; Azuma Kanatsuka; Atsunori Kashiwagi
Journal:  J Diabetes Investig       Date:  2013-12-01       Impact factor: 4.232

9.  Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.

Authors:  Amir Sarayani; Arash Rashidian; Kheirollah Gholami
Journal:  BMJ Open       Date:  2014-10-16       Impact factor: 2.692

10.  Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013.

Authors:  Kristin K Clemens; Salimah Shariff; Kuan Liu; Irene Hramiak; Jeffrey L Mahon; Eric McArthur; Amit X Garg
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.